Stem Cells

Stem cell research is an important way to explore new possibilities to improve patient care

More Areas of Research

About Stem Cell Research

Our goal is to use stem cell therapy to help patients with chronic chest pain. Stem cells are harvested from the patient’s own bone marrow and are used to help repair the small vessels of the heart.

Stem cells are capable of developing into other specialized kinds of cells within the body. This makes them useful in research because they may be able to repair damaged tissue or blood vessels and, in some cases, even help form new vessels and tissue.

Jeff Fraser: Coronary Artery Disease

One Stem Cell Research Patient Story

"I participated in research because it may or may not help me, but hopefully it helps somebody in the future."

Stem cell research is frequently mentioned as a new possibility to study diseases in many parts of the body. Cardiovascular stem cell research is a growing field and initial studies are finding new possibilities for treatment.

See one patient's experience with stem cell research and some of the steps involved in the process.

Read Jeff's Story

On the Pulse

Dr. Jay Traverse joined us for An Update on Cardiovascular Stem Cell Therapy & the Potential Treatment of COVID-19 at On the Pulse

Meet Our Team

Benjamin Sun, MD

Benjamin Sun, MD

Cardiothoracic Surgeon

Jay Traverse

Jay Traverse, MD

Senior Consulting Cardiologist & Board Member

Old man smiling

Make a Life-Changing Donation

Any gift, small or large, advances transformative research to save lives.

Donate

Give the Gift of Hope

4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background

Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.